Metsera (MTSR) issued the following statement in response to litigation filed against the company by Pfizer (PFE): “Metsera disagrees with the allegations in Pfizer’s complaint and will address them in the Delaware Court of Chancery.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Pfizer (PFE) Sues Metsera and Novo Nordisk Over Disputed Obesity Drug Merger
- Pfizer files lawsuit against Metsera, Novo Nordisk for breach of merger pact
- Pfizer receives early clearance from FTC for Metsera acquisition
- Pfizer Could Call on Best Buddy Trump to Help Win $8.5B Novo Nordisk Bidding War
- Trump Trade: China to work with U.S. to resolve TikTok issue